Chloroprocaine Hydrochloride 30 mg/g eye gel

DRUG2 trials

Sponsors

Sintetica S.A.

Conditions

aged 0-17 years scheduled to undergo ocular exams with a need of ocular surface anesthesia.male/female outpatients

Phase 3

A prospective, observer-blind, randomized clinical trial to investigate and compare the clinical efficacy of Chloroprocaine 3% gel and Oxybuprocaine 0.4% eye drops anesthesia for clinical practice in pediatric population.

WithdrawnCTIS2023-504477-21-00

Sintetica S.A.aged 0-17 years scheduled to undergo ocular exams with a need of ocular surface anesthesia., male/female outpatients

Target: 74Updated: 2023-09-26

A prospective, observer-blind, randomized clinical trial to investigate and compare the clinical efficacy of Chloroprocaine 3% gel and Oxybuprocaine 0.4% eye drops anesthesia for clinical practice in pediatric population.

CompletedCTIS2023-504477-21-01

Sintetica S.A.aged 0-17 years scheduled to undergo ocular exams with a need of ocular surface anesthesia., male/female outpatients

Start: 2024-05-14End: 2025-03-13Target: 74Updated: 2024-12-13